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Abstract
As more is learned about glycoproteins’ roles in human health and disease, the biological 
functionalities of N-linked glycans are becoming more relevant. Protein deglycosylation allows for 
the selective release of N-glycans and facilitates glycoproteomic investigation into their roles as 
prebiotics or anti-pathogenic factors. To increase throughput and enzyme reusability, this work 
evaluated several immobilization methods for an endo-β-N-acetylglucosaminidase recently 
discovered from the commensal Bifidobacterium infantis. Ribonuclease B was used as a model 
glycoprotein to compare N-glycans released by the free and immobilized enzyme. Amino-based 
covalent method showed the highest enzyme immobilization. Relative abundance of N-glycans 
and enzyme activity were determined using matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry. Kinetic evaluation demonstrated that upon immobilization, both Vmax 
and the Km decreased. Optimal pH values of 5 and 7 were identified for the free and immobilized 
enzyme, respectively. Although a higher temperature (65 vs. 45 °C) favored rapid glycan release, 
the immobilized enzyme retained over 50% of its original activity after seven use cycles at 45 °C. 
In view of future applications in the dairy industry, we investigated the ability of this enzyme to 
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deglycosylate whey proteins. The immobilized enzyme released a higher abundance of neutral 
glycans from whey proteins, while the free enzyme released more sialylated glycans, determined 
by nano-LC Chip Q-ToF MS.
Keywords
N-glycans; mass spectrometry; immobilization; prebiotic; glycosidase; recombinant; kinetic; 
nano-LC Chip Q-ToF MS
1. Introduction
Glycoproteins are a biologically important class of components with modulatory roles in 
signaling and cell adhesion. N-linked glycans are covalently bound to an asparagine residue 
with the consensus sequence on the primary structure of asparagine-X-serine/threonine (with 
X representing any amino acid besides proline) [1]. The attachment is mediated by the 
reducing end N-acetylglucosamine moiety of the glycan onto the asparagine residue [2]. All 
N-glycans share a common trimannosyl, chitobiose (two β-1,4 linked N-acetylglucosamine 
residues) core and are classified based on how the core is elongated with various 
monosaccharides. N-glycans can be decorated with N-acetylneuraminic acid or N-
glycolylneuraminic acid (sialylated) and/or fucose (fucosylated) in various antennary 
combinations to give rise to a heterogeneity of combinations, even on a single glycosylation 
site. Glycans can be classified based on their antennary decorations, with neutral, 
fucosylated, sialylated, and both fucosylated and sialylated being the primary non-plant 
glycans.
As a model for understanding the interplay of indigestible carbohydrates and beneficial gut 
bacteria, human milk oligosaccharides (HMOs) have been widely studied and found to 
exhibit uniquely effective prebiotic functionalities [3]. While HMOs are quite abundant in 
human milk (up to 15 g/L in colostrum), their commercial-scale isolation from human milk 
is not feasible [4]. The activities and roles of intact and released N-linked glycans upon 
human consumption are not well understood due, in part, to the lack of adequate 
deglycosylation and analytic methods to release, identify, and quantity the released glycans 
[5]. N-glycans can be released from the protein moiety using harsh chemical treatments or 
enzymatic methods, the latter allowing for the recovery of intact protein and glycans. 
Deglycosylating enzymes include peptide-N-glycosidases and endo-β-N-
acetylglucosaminidases, which differ in cleavage points of the core of N-glycans [6].
Due to striking similarities in structures and functions, released N-linked glycans from 
bovine milk glycoproteins have been studied for their ability to promote the growth of 
commensal bacteria in vitro [7,8]. A recently discovered endo-β-N-acetylglucosaminidase 
(Endo-BI-1), isolated from B. infantis, was shown to deglycosylate human milk 
glycoproteins more effectively than other endo-β-N-acetylglucosaminidase isolated from 
several commensal Bifidobacterium species [9]. More importantly, released N-glycans by 
this novel enzyme from bovine milk proteins displayed a remarkable selective prebiotic 
activity on Bifidobacterium longum subsp. infantis in vitro, and may promote the growth of 
other beneficial bacteria while inhibiting pathogens [7,8,10]. However, to establish N-
Cohen et al. Page 2
Catalysts. Author manuscript; available in PMC 2019 March 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
glycans as an alternative source of prebiotic carbohydrates to human milk, further research 
into the selectivity of bovine N-glycans and their functional similarity with HMOs with 
respect to commensal, beneficial, and pathogenic gut organisms is necessary.
Whey, the co-product of cheese manufacture, is a potential commercially available source of 
underutilized glycoproteins. The concentration of proteins in bovine cheese whey ranges 
from 1 to 2%, wherein approximately 4–9% of those proteins are N-glycosylated 
immunoglobulins, lactoferrin, and transferrin [11,12]. Lactoferrin, while found in substantial 
quantities in human milk and bovine colostrum, is present in bovine milk and cheese whey 
at the trace level.
Yet, the nearly 200 million tonnes of whey produced each year globally [13] conservatively 
translates to 2 million tonnes of whey proteins, corresponding to approximately 100,000 
tonnes of bovine milk glycoproteins available for subsequent processing. With such a large 
availability of glycoproteins, the development of large-scale processing strategies to release 
and isolate N-glycans for further characterization and elucidation of their biological 
functionalities becomes a key step for further commercialization of these compounds.
Indeed, enzyme immobilization may facilitate reaction scale-up considering the possibility 
for broad reactor systems and catalyst reusability. Enzyme immobilization is the process 
wherein a soluble enzyme is attached or adsorbed onto a solid support, entrapped within a 
matrix, or otherwise aggregated enabling enzyme reuse during production [14]. However, 
widespread industrial use of immobilized enzyme remains limited due to a perceived loss of 
enzyme activity, lack of universal immobilization techniques, and cost implications [15,16]. 
In general, enzyme immobilization facilitates the separation of products and catalyst where 
removal from the final product to terminate the reaction and to reuse the catalyst is important 
in producing pure bioactive molecules. Covalent, adsorption, entrapment, and aggregation 
methods of immobilization have their inherent advantages and disadvantages in a reactor 
system. These factors are based on substrate size and ability to access the enzyme active site, 
physicochemical stability, and applicability in industrial processes [15]. Although the use of 
immobilized enzymes has been validated by the food industry to a limited extent [17], the 
use of glycosidases has been restricted to lab-scale [6].
The overall goal of this study was to evaluate several types of immobilization methods and 
resins for a novel endo-β-N-acetylglucosaminidase (Endo-BI-1) isolated from B. infantis. In 
addition to the development of an immobilization method based on protein immobilization 
yield and enzyme activity, the effects of the immobilization method on pH and temperature 
sensitivity of the immobilized enzyme were evaluated. Enzyme reusability was also 
evaluated. Significant efforts were directed towards the development of sensitive and high-
throughput analytical methods: in particular, MALDI-ToF MS was used to study the rate and 
specificity of the deglytosylation reaction kinetics on RNase B, and nano-LC-Chip Q-ToF 
MS was used to characterize the diverse pool of N-glycans released from bovine colostrum 
whey proteins using free end immobilized enzyme.
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2. Results and Discussion
2. 1. Protein Immobilization Yield
Enzyme immobilization yield of amino-, epoxy- and adsorption-immobilized Endo BI-1 was 
evaluated by quantifying the unbound protein remaining in the supernatant and resin 
washing buffer post-immobilization. The fluorescence method employed herein (Qubit 
Protein Assay Kit) demonstrated the high immobilization yield (>98%) of the amino-based 
resin, whereas divinylbenzene (DVB)-based hydrophobic interaction adsorption 
immobilized 70% of the enzyme (Figure 1). Epoxy-based covalent binding yielded the 
lowest immobilization yield at 12%. These results were corroborated by SDS-PAGE, where 
denser Endo BI-1 bands in the supernatants were present in epoxy and adsorption methods, 
while amino-based immobilization had no visible band (Figure S1). Differences between 
immobilization yields for covalent and adsorption immobilization methods have been 
observed previously and can possibly be attributed to the strength of interaction between 
hydrophobic interactions and covalent bonds [18]. However, low binding using epoxide-
activated resin may be due to non-optimal methods to identify the ideal pH, time, and 
temperature for increased binding [19]. Further investigation into those conditions may 
improve protein immobilization yield for the epoxide-activated resin.
2.2. Relative Quantification of N-glycans by MALDI-ToF MS
An additional goal of this research was to identify a sensitive, specific, and rapid method to 
determine relative quantities of N-glycans to facilitate assessment of enzyme activity. 
Spectrophotometric methods involving phenol-sulfuric acid have been used, but lack 
selectivity for certain saccharide types and tend to be affected by other compounds present 
in the sample, not only the N-glycan products of this reaction [20–22]. Additionally, the 
diverse array of monosaccharides present in N-glycans adds a layer of complexity leading to 
inconsistent responses in these assays [21]. As an alternative, matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry MALDI-ToF MS has been used for 
relative quantification of various carbohydrates [23,24]. It is known that MALDI-ToF, albeit 
rapid and effective in providing results, may suffer from low reproducibility due to 
inconsistent crystallization of the samples on the target plate, leading to shot-to-shot 
variation. These disadvantages can be overcome by using an internal standard [25]. 
Additionally, MALDI has been used to study enzymatic reactions including both large and 
small substrates/products [26–28].
Linearity of the 3-FL (3′-fucosyllactose)-spiked released N-glycan system was evaluated. 
An example of a typical annotated mass spectrum of N-glycans can be seen in Figure 2. The 
theoretical m/z for sodiated 3-FL, Man 5, Man 6, Man 7, and Man 8 are 511.16, 1054.34, 
1216.40, 1378.45, and 1540.50 respectively, accounting for one fewer N-acetylglucosamine 
residue according to cleavage by Endo BI-1. The most abundant glycan released from 
RNase B was Man5 (m/z 1054), with larger glycans being less abundant, which was 
consistent with previous literature [29]. Bovine RNase B was chosen as a model 
glycoprotein due to its single N-glycosylation site and straightforward glycan composition.
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Over the examined order of magnitude range, the normalized response plotted against N-
glycan/I.S. (internal standard) ratio was linear (R2 = 0.995, Figure S2). A high R2 value 
indicates that analysis of released N-glycans in presence of I.S. analyzed by MALDI-ToF 
MS is a suitable tool for rapid relative quantification of N-glycans needed for evaluating 
kinetic parameters over a substantial range of concentrations and amounts of reactant.
2.3. Comparing Immobilized Enzyme Activities
The activity of the enzyme immobilized by each method (amino, epoxy, and adsorption) was 
evaluated on RNase B, and reacted for 90 min at 45 °C and pH 5.0. The normalized relative 
abundance of released N-glycans was determined by MALDI-ToF MS, with activity based 
on the amount of glycans released by the free enzyme (Figure 3). Free enzyme had the 
highest activity, with amino, epoxy, and adsorption methods retaining 73, 51, and 57% 
activity, respectively. Diminished activity upon immobilization is common, and has been 
reported previously with glutaraldehyde-mediated binding and hydrophobic adsorption [30]. 
A combination of diffusional/steric hindrances and possible binding and occlusion of 
enzyme active sites may explain the reduction in enzyme activity [16]. Additionally, 
heterogeneous catalysis impacts enzyme activity. The amino-based immobilization was 
selected for all subsequent experiments due to its higher activity compared with epoxy and 
adsorption methods, as well as its improved catalyst density on the resin.
2.4. Temperature and pH Sensitivity of Immobilized Enzyme Using RNase B
Enzyme properties can change with respect to pH and temperature sensitivity when 
immobilized [31,32]. Temperature sensitivity was evaluated at pH 5 with 20 mM Na2HPO4 
buffer at temperatures from 45 to 85 °C (Figure 4a). The optimal temperature for both free 
and immobilized Endo BI-1 was 65 °C. These results differ from what was previously 
reported by Karav et al. [33], in which a lower optimum temperature of 52 °C was identified 
for the free enzyme. This discrepancy could be attributed to different reaction conditions 
used in both studies. While RNase B and a short reaction time (20 min) were used in the 
present work, bovine colostrum whey protein and longer reaction times (15–475 min) were 
evaluated in the previous study. At the optimum temperature identified (65 °C), the 
immobilized enzyme retained 63% of the activity compared with the free enzyme. In each 
experimental condition of both temperature and pH, the activity of immobilized Endo BI-1 
was lower than that of the free enzyme, at all conditions. For both free and immobilized 
enzymes, activities decreased at temperatures above 65 °C.
To evaluate pH sensitivity, 20 mM Na2HPO4 buffer was adjusted to pH 3, 5, 7, and 9. 
Reactions with free and immobilized Endo BI-1 and RNase B were carried out at 45 °C for 
20 min, and the normalized activity can be seen in Figure 4b. The optimal pH for free Endo 
BI-1 was 5, in agreement with previous reports [9], while for the immobilized enzyme a 
shift to a neutral pH (7.0) was observed. At the optimal pH for the free (pH 5) and 
immobilized enzyme (pH 7), the immobilized enzyme retained approximately 62% of the 
activity of the free enzyme at 20 min of reaction. However, the immobilized enzyme was 
more resilient in the range of pH 7 to 9, where reduced differences in the activities of the 
free and immobilized enzyme were observed. Indeed, at pH 9, the activities of free and 
immobilized Endo BI-1 were not statistically different (Figure 4a). Our results are in 
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agreement with several reports in the literature where a shift on the working pH of the 
immobilized enzyme to a neutral or more alkaline pH was observed, with the same being 
attributed to changes in the amine group during the covalent binding [31,34]. In the context 
of scaling up N-glycan release using bovine milk proteins, the optimum pH of the 
immobilized enzyme (pH 7), presents a clear advantage over the free enzyme, considering 
that milk and dairy streams naturally have a pH close to neutral and would not necessitate 
the use of buffers for pH adjustment, which can become problematic and costly at large 
scale. Literature suggests that immobilization alters temperature and pH sensitivity by 
stabilizing the enzyme conformation and creating stable microenvironments around the 
enzyme or close to its active site [35]. The data here presented provides valuable information 
for future scale-up of the process and testing other substrates for glycan release.
2.5. Enzyme Kinetics Using RNase B
To gain more quantitative insight into the mechanistic changes of the enzymatic 
deglycosylation upon immobilization, the kinetic parameters (Vmax, Km) were estimated 
using linearized plotting techniques (Lineweaver-Burk and Hanes Woolf) to reduce the error 
of non-linear estimation (Figure 5). Vmax, the maximum forward velocity of the reaction, 
decreased from 0.551 glycan/min to 0.076 glycan/min (Lineweaver Burk estimation) upon 
immobilization of Endo BI-1 as calculated on RNase B (Figure 6). The Michaelis constant 
(Km, a measure of substrate affinity) also decreased upon immobilization from 2.27 mg/mL 
for the free enzyme to 0.299 mg/mL once Endo BI-1 was immobilized on the amino-
activated methacrylate resin. The goodness-of-fit for the Lineweaver Burk linear model (R2) 
for free and immobilized enzyme was 0.89 and 0.96 respectively. Hanes Woolf linear 
estimation revealed similar trends (0.333 and 0.081 Vmax values, 1.17 and 0.345 Km values 
for free and immobilized enzymes, respectively) to Lineweaver Burk. Decreased Vmax is 
typical of enzyme immobilization [32,36], wherein lower maximum velocity is likely due to 
limited access of the large, macromolecular substrate to the active site of the immobilized 
enzyme. The immobilized enzyme is on a molecular tether, and steric hindrances limit 
access to more occluded glycan sites on the substrate with respect to the three-dimensional 
structure. As a point of comparison, β-1,4-galactosidase, with a molecular weight of 
approximately 465 kDa in its tetrameric form, with lactose as substrate at 360 Da has an 
overall substrate/enzyme size ratio of 0.0008:1, whereas for RNase B and Endo BI-1, the 
substrate/enzyme size ratio is approximately 0.32:1. This suggests a more limited diffusion 
and increased steric challenge with respect to active site availability.
Increased apparent affinity accompanied by decreased Vmax is consistent with uncompetitive 
inhibition. Possible explanations of this phenomenon are the formation of a more stable 
enzyme-substrate complex between Endo BI-1 and RNase B upon immobilization, or simply 
deglycosylated RNase B may have difficulty diffusing away from immobilized Endo BI-1 
upon interaction with the active site. Both stable enzyme-substrate complexes and 
diffusional challenges would increase apparent affinity and inhibit forward reaction progress 
and are documented phenomena [36,37]
Enzymes with diverse, macromolecular substrates may exhibit substrate-dependent kinetic 
behavior. For example, when Endo BI-1 was tested on different glycoproteins, Vmax and Km 
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also varied. The Michaelis constants for RNase B, lactoferrin, and concentrated whey 
proteins were 0.25, 0.43, and 0.90 mg/mL respectively, potentially due to different sizes, 
purities, and physicochemical properties of the glycoproteins [20]. The overall increase in 
Km for Endo BI-1 in this study (0.33 vs. 025 mg/mL) is likely related to differences in 
reaction conditions and analytical methods used in both studies. While this study utilized 
MALDI-ToF MS to measure the hydrolytic efficiency of Endo BI-1, previous studies 
utilized a spectrophotometric phenol-sulfuric assay, wherein the diverse array of 
monosaccharides present in N-glycans from lactoferrin and other whey proteins could have 
yielded different responses.
2.6. Immobilized Enzyme Reusability with RNase B
A substantial advantage of enzyme immobilization is the potential reusability of the catalyst. 
Amino-mediated immobilized Endo BI-1 was subjected to ten 20-min reuse cycles at 45 and 
65 °C to determine the effects of different temperatures on the activity and reusability of the 
immobilized enzyme (Figure 6). Enzyme activity was higher at 65 °C compared with 45 °C. 
At 45 °C, the immobilized enzyme activity corresponded to approximately 65% of the 
enzyme activity at 65 °C. Despite higher enzyme activity at 65 °C, a higher decrease in the 
enzyme activity was observed after each reuse cycle. At 65 °C, enzyme activity was reduced 
to 63% of its original value after one cycle of reuse, and by the sixth use cycle, it had been 
reduced to and stabilized at 10 to 15% of its original activity. Conversely, at 45 °C, the 
enzyme activity remained consistent up to three reuse cycles. Despite the initial higher 
enzyme activity at 65 °C, from the third cycle onward reactions at 45 °C had greater residual 
enzyme activity than reactions performed at 65 °C. These results indicate that although 
65 °C is optimal for initial glycan release, it does not favor repeated enzyme use for longer 
reaction times. It is possible to reuse the immobilized enzyme up to seven cycles at 45 °C 
with significant retention of its activity (50% from the initial activity). Our results are in 
agreement with several reports in the literature, where the use of lower temperatures (e.g., 
37 °C) has favored high reusability, even though higher temperatures may favor more rapid 
catalysis [38,39]. Regarding an industrially-relevant enzyme with macromolecular 
substrates, Chauhan reported a loss of over 85% of polygalacturonase activity after 6 cycles 
using adsorption onto celite [40]. Additionally, reaction time and temperature affect the 
selective release of N-glycans from more complex and diverse glycoproteins, which may 
determine the choice of the reaction temperature thus affecting reusability of the 
immobilized enzyme [41]. Importantly, fouling with a protein-based substrate may also 
impact reusability [42].
2.7. Release of N-glyans from Bovine whey Proteins
Cheese whey, a co-product of the dairy industry, is a source of N-linked glycoproteins 
including lactoferrin, lactoperoxidase, transferrin, and various immunoglobulins [12]. Free 
and immobilized Endo BI-1 was incubated with whey proteins purified from bovine 
colostrum at pH 7 at 45 °C for 1 h. The glycans were purified and characterized by nano LC-
Chip Q-ToF mass spectrometry and each compound’s relative abundance was determined 
and further classified based on the class of glycan to which each compound belongs (Figure 
7).
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Overall, twenty-six unique N-glycan structures were identified and confirmed by tandem 
mass spectra. The N-glycans were characterized based on their monosaccharide 
composition, which included neutral (containing only hexose and N-acetylhexosamine 
residues), sialylated, fucosylated, and fucosylated and sialylated. For neutral glycans the 
immobilized enzyme released eight times higher relative amounts than free Endo BI-1. For 
the class fucosylated and sialylated, the free enzyme released significantly higher amount of 
glycans (approximately double) compared with the free enzyme. Free enzyme released 50% 
more of each fucosylated and sialylated glycan class. For glycans with both sialylation and 
fucosylation, the free enzyme released nearly double the relative amount of glycans 
compared with immobilization. It is worth mentioning that fucosylated and sialylated 
glycans were present in lowest amounts. Both sialylated and neutral glycans represented the 
most abundant glycan types released from colostrum whey proteins. Importantly, unique 
glycan compositions should only be compared between samples, and not among the various 
N-glycan structures themselves. In fact, differences in ionization efficiency due to diverse 
monosaccharide composition hinder direct comparisons in the absence of identical pure 
standards.
The N-glycan structures released by Endo BI-1 were tabulated according to the glycan 
composition notation Hex_HexNAc_Fuc_NeuAc_NeuGc, which correspond with the 
number of hexose, N-acetylhexosamine, fucose, N-acetylneuraminic acid, and N-
glycolylneuraminic acid residues respectively (Table SI). The most abundant glycans 
released from colostrum whey proteins by free Endo BI-1 were 4_3_0_1_0 and 3_3_0_1_0 
while the most abundant glycan structures released by immobilized Endo BI-1 were 
3_3_0_0_0 and 5_1_0_0_0 (Man5). The relative abundance for released 3_3_0_0_0 and 
5_1_0_0_0 for immobilized enzyme compared with free enzyme were 27 and 14 times 
higher, respectively. These large differences are the main drivers of the substantial 
differences in relative abundance of neutral glycans. Both 3_3_0_0_0 and 4_3_0_1_0 were 
identified as the most abundant glycans released from a similar protein source using Endo 
BI-1 [41]. Although high mannose compounds like 5_1_0_0_0 and 6_1_0_0_0 were 
previously found in the bovine and human milk N-glycome, likely deriving from bovine 
lactoferrin, they were not previously described as being released from bovine colostrum 
whey proteins with free Endo BI-1 [41,43].
Despite the many technological breakthroughs, deglycosylation is still not a well-
characterized process. Recently, the kinetics of the commercial enzyme peptide-N-
glycosidase F (PNGase F) were investigated to understand the impact of sialylation on the 
release of N-glycans [44]. Presence of sialic acid slowed glycan release, while fucosylation 
also affected the deglycosylation rate. Because RNase B contains a single glycosylation site 
and high mannose type glycans, these differences would not be observed. However, when 
using a different enzyme (Endo BI-1) and complex substrates like bovine colostrum whey 
proteins under different conditions, kinetics and deglycosylation behavior would likely be 
substantially different. Additionally, the presence of methacrylate resin with pore diameters 
within the range of 300 to 600 Å may facilitate binding of small, neutral glycans such as 
3_3_0_0_0 and 5_1_0_0_0 or the protein regions containing them, favoring their release 
compared with free Endo BI-1. Antennary moieties such as fucose or sialic acid could also 
change physicochemical interactions between the glycan and the methacrylate supports as 
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well as the glycan with the immobilized enzyme itself. The ability to modulate glycan 
release based on reaction conditions has been previously described by Le Parc et al. [41]. 
Additional changes on the glycan release resulting from the immobilization method used 
suggests a high degree of complexity concerning enzymatic deglycosylation.
3. Materials and Methods
3.1. Enzyme Production
Recombinant endo-β-(1,4)-N-acetylglucosaminidase (Endo BI-1) from Bifidobacterium 
longum subsp. infantis ATCC 15697 from the University of California Davis Viticulture and 
Enology Culture Collection (Davis, CA, USA) was cloned into E. coli using a pEcoTM-T7-
cHis cloning kit (GeneTarget Inc, San Diego, CA, USA). Endo BI-1 was expressed and 
isolated in a stock containing 65 mg/mL enzymebased upon previous literature [33].
3.2. Enzyme Immobilization
Endo BI-1 was immobilized onto methacrylate resin according to manufacturer’s directions 
(Purolite, Llantrisant, Wales, UK). Epoxide-activated (Lifetech ECR8204F), amino-activated 
(Lifetech ECR8309F), and divinylbenzene (DVB, Lifetech ECR1030M) adsorption resins 
were used in this study. Covalent (epoxide- and amino-activated resins) and adsorption 
(divinylbenzene resin) immobilization techniques were selected in this study due to limited 
macromolecular substrate diffusion through entrapment matrices [45].
To activate the amino resin, 2% glutaraldehyde in 1× PBS as a crosslinking agent was added 
to the resin prior to enzyme addition and incubated for 1 h, after which it was washed with 
0.1× phosphate-buffered saline (PBS) to remove excess glutaraldehyde. Endo BI-1 enzyme 
stock was added to each activated resin (50 mg enzyme per gram activated resin, wet basis) 
in buffer mass equal to four times the mass of the resin. For epoxide-activated 
immobilization, resin was incubated with enzyme in 10× PBS buffer for 42 h. For 
adsorption-based immobilization, DVB resin was incubated with enzyme for 18 h in 0.1× 
PBS buffer. Amino-based immobilization was incubated with enzyme in 0.1× PBS for 24 h, 
based on the manufacturers’ recommendations. Enzyme incubation took place at 25 °C and 
100 rpm and each immobilization method was performed in triplicate. Following incubation, 
resins were washed with four volumes of 0.1× PBS buffer. The wash buffer was collected 
and further analyzed to determine the protein immobilization yield.
3.3. Evaluating Protein Immobilization Yield
Wash buffers from enzyme immobilization were treated with four volumes of −20 °C 
ethanol and held at −30 °C for 60 min to precipitate proteins, after which the samples were 
centrifuged at 4000× g for 30 min at 4 °C. The supernatant was discarded, and the pellet was 
resuspended in nanopure water. The total protein was loaded to the immobilization resin and 
the protein remaining in the wash buffer was measured. The protein immobilization yield 
was determined by the following equation:
Protein immobilization yield % =
PL − Pw
PL
× 100 %
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where PL is the mass of protein loaded and Pw is the mass of protein in the resin washing 
buffer after immobilization [46]. Total protein was measured fluorometrically in triplicate 
using the Qubit Protein Assay Kit (Life Technologies, Grand Island, NY, USA). Purified 
protein samples were also analyzed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) on 4–15% precast polyacrylamide gels to visualize amount of 
protein not bound to immobilization resin [9].
3.4. N-glycan Analysis by MALDI-ToF Mass Spectrometry
A microflex MALDI-ToF mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany) 
was used. Ten μL of purified N-glycan samples were spiked with five μL 100 mg/L of the 
human milk oligosaccharide 3′-fucosyllactose (3-FL, Dextra Laboratories Inc., Reading, 
UK) as an internal standard. A one μL aliquot of spiked sample was combined with an equal 
volume of 2,5-dihydroxybenzoic acid matrix (20 mg/mL in 30% acetonitrile, 0.1% 
trifluoroacetic acid) and 0.4 μL 1 mM NaCl was added to achieve ionization in positive 
mode. 0.5 μL spiked sample with matrix and NaCl was spotted in duplicate onto a ground 
steel target plate and dried under vacuum. Mass calibration was conducted using a 
polysaccharide ladder extracted from beer [47].
Ionization was carried out using a 337.1 nm laser, and detected in reflectron positive mode 
with a reflector voltage of 20.02 kV in the mass range of 300 to 2500 m/z. The final spectra 
were the sum of 2000 laser shots. MS intensities of four glycans (namely Man 5, Man 6, 
Man 7, Man 8) released from bovine ribonuclease B (RNase B, Sigma Aldrich, St. Louis, 
MO, USA) were normalized to the MS intensity of 3-FL internal standard, summed, and 
considered the normalized relative abundance of glycan.
Linearity of the MALDI-ToF method was determined by preparing a stock of glycans 
released from RNase B using free Endo BI-1. Following purification as described above, 
varying amounts of released N-glycan was added to a constant amount of 3-FL internal 
standard and analyzed by MALDI-ToF MS as described above. The summed, normalized 
intensity was plotted against the volume of N-glycans added and a linear regression was fit 
to the data.
3.5. Preliminary Comparison of Immobilization Methods Efficiency Using Ribonuclease 
(RNase) B
Accounting for varying immobilization yields of the enzyme onto the beads, resin 
containing 40 μg immobilized Endo BI-1 or 40 μg free enzyme was reacted with 600 μg in 
20 mM Na2HPO4 buffer for 90 min at 45 °C at pH 5. The reaction was terminated with 
ethanol at −30 °C and glycans were purified and characterized as described in the MALDI-
ToF MS analysis section. Summed, normalized MS intensities for the four most abundant 
glycans were normalized to 100% activity for the free enzyme. One-way analysis of 
variance (ANOVA) was used along with Tukey’s multiple comparisons test with GraphPad 
Prism 7 (Graphpad, La Jolla, CA, USA) to determine the statistical significance of the data 
at p < 0.05.
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3.6. Effect of Immobilization on Enzyme Resilience to pH and Thermal Changes
To identify the optimum temperature for the immobilized enzyme, RNase B was incubated 
in pH 5 buffer as described previously and free or immobilized enzyme was added [9]. The 
reaction mixture (enzyme + substrate) was incubated for 20 min at temperatures ranging 
from 45 to 85 °C. Their respective deglycosylating activities were normalized and 
compared.
The pH of 20 mM Na2HPO4 buffer was adjusted to 3, 5, 7, and 9 using 1 N HCl or NaOH. 
Free and immobilized Endo BI-1 was reacted with RNase B at 45 ° C at each pH for 20 min 
and the relative activity, measured as the enzyme ability to deglycosylate RNase B, was 
measured by MALDI-ToF MS. Experiments were conducted in triplicate and a two-way 
ANOVA was used along with Tukey’s multiple comparisons in GraphPad Prism 7 to 
determine statistical significance of the data at p < 0.05.
3.7. Determination of Kinetic Parameters of Enzyme Using RNase B
Relevant kinetic parameters relating to maximum reaction velocity (Vmax) and the 
Michaelis-Menten constant (km) were determined by measuring the normalized glycan 
intensity at varying substrate concentrations (0.1 to 1.1 g/L) in 20 mM Na2HPO4 buffer 
under optimal pH and temperature conditions for the free and immobilized enzyme. Aliquots 
were taken in four-minute intervals up to 20 min. Linearized plotting (Lineweaver Burk and 
Hanes Woolf) were utilized to calculate Km and Vmax [48,49].
3.8. Evaluating Reusability of Immobilized Endo BI-1 Using RNase B
Reusability of immobilized Endo BI-1 was evaluated for ten cycles of 20 min at both 65 °C 
and 45 °C in presence of RNase B. Between each cycle, the supernatant from the reaction 
was removed and subsequently treated with cold ethanol for protein precipitation and glycan 
isolation. After each reaction cycle, the remaining resin containing the immobilized enzyme 
was washed with a 20 mM Na2HPO4 buffer at a 4:1 ratio (buffer/reaction volume) and fresh 
substrate-containing buffer was added for the next reaction cycle. Enzyme activity after the 
first reaction was considered as 100%. Experiments were conducted in triplicate.
3.9. Release of N-glycans from Bovine Colostrum whey Proteins by Free and Immobilized 
Endo BI-1
Bovine colostrum whey proteins were isolated from bovine colostrum whey kindly provided 
by La Belle (Bellingham, WA, USA). Bovine colostrum whey proteins were isolated and 
purified using a 10 kDa molecular weight cut-off ultrafiltration as described previosly by 
Karav et al. [33] and were deglycosylated by free and immobilized Endo BI-1 in triplicate. 
Bovine colostrum whey protein concentration was determined by Qubit fluorometric kit 
according to manufacturer’s instructions as described previously. Briefly, Endo BI-1 (free or 
immobilized) was added to purified colostrum whey proteins at a ratio of 1:75 in 20 mM 
Na2HPO4 buffer at pH 7 and reacted for 1 h at 45 °C based on previous reports [33]. The 
reaction was terminated, and proteins were precipitated using cold ethanol. The supernatant 
was dried by vacuum centrifuge and subsequently resuspended, whereupon glycans were 
purified from contaminants using C18 cartridges (Glygen, Columbia, MD, USA) and 
desalted by porous graphitized carbon (PGC, Glygen) solid phase extraction as described 
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previously [7,50]. Eluate from PGC was dried, resuspended in nanopure water for 
subsequent nano-LC-Chip Q ToF analysis.
3.10. N-glycan Analysis by Mass Spectrometry Nano-LC-Chip Q ToF
Samples were transferred to polypropylene vials and 6 μL were injected into an Agilent 
6520 nano-LC-Chip quadrupole time-of-flight mass spectrometer (Q-ToF MS, Agilent 
Technologies, Santa Clara, CA, USA). Glycans were further purified on a 9 mm × 75 μm 
PGC enrichment column and then separated on a 43 mm × 75 μm PGC analytical column 
with binary solvents, gradient, and data collection based on Karav et al. [7]. The following 
minor modifications were applied: scan range for MS was 450 to 2500 m/z, and for MS/MS 
was 100 to 3200 m/z. Spectra in both MS and MS/MS modes were collected at a rate of 0.63 
spectra/s. The collision energy in the collision cell corresponded to a slope of 1.8/100 Da.
Chromatograms from the nano-LC-Chip Q ToF were curated and compounds identified in 
Masshunter Qualitative Analysis software (version B.07.00 Agilent Technologies) using a 
previously described bovine milk N-glycan bioinformatic library adjusted for one fewer N-
acetylglucosamine in the chitobiose core. The library assumed compositions including 
hexose (Hex), N-acetylhexosamine (HexNAc), fucose (Fuc), N-acetylneuraminic acid 
(NeuAc), and N-glycolylneuraminic acid (NeuGc) [43]. Additionally, structures included a 
tetrasaccharide core containing three hexose (e.g., mannose) moieties and one HexNAc (N-
acetylglucosamine) moiety. Structures were confirmed using MS/MS fragmentation patterns 
and isotopic distribution. A library of glycan structures specific to the sample set was 
assembled based on retention time, molecular formula and confirmed m/z. Relative 
abundances of N-glycans were obtained using Masshunter Profinder software (version B.
06.00, Agilent Technologies). The batch targeted feature extraction algorithm with the 
following parameters was applied using the generated database: minimum abundance of 750 
counts, charge state up to +3, retention time window of 2 min, and a glycan isotope model. 
Peak areas were verified for accurate integration and isotopic distribution.
4. Conclusions
These findings highlight the advantages and limitations of different enzyme immobilization 
strategies, in particular when considering an enzyme targeting the release of glycans from 
macromolecular substrates such as glycoproteins. The immobilization process shifted the 
optimum pH of the enzyme to a neutral pH, which is of relevance when considering the 
immobilization of this enzyme for industrial applications, such as in dairy products or other 
food products having a pH close to neutral. The use of moderate temperatures favored the 
reuse of the immobilized enzyme. Immobilized enzyme reusability may compensate for its 
initial reduced activity. When using a complex and diverse source of glycoproteins as bovine 
colostrum, the immobilized enzyme released a higher abundance of neutral N-glycans than 
the free enzyme, which yielded a different overall composition of glycans by class. This 
difference suggests that specific glycan release can be achieved by potentially tailoring 
immobilized enzyme reactions conditions in future studies.
Further investigation of the different rates of glycan release, possibly due to limited enzyme 
accessibility to specific glycan sites on glycoproteins, may enhance our understanding of the 
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role of certain glycosylation sites and structures on their function, in particular for 
therapeutic glycoproteins such as monoclonal antibodies. Investigation on alternative 
glycoprotein substrates of plant origin is warranted to understand substrate specificity. This 
study presents a scalable technique for enzymatic deglycosylation of industrially relevant 
glycoproteins. Optimized reactor configurations, including flow-through column reactors 
and fluidized beds, could favor glycan release and subsequent isolation from deglycosylated 
proteins in downstream isolation, enabling future processing scale-up and commercialization 
of bioactive glycans and novel therapeutics.
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Figure 1. 
Protein immobilization yield for amino, adsorption, and epoxy immobilization methods, 
measured fluorometrically by Qubit Protein Assay Kit. Error bars represent one standard 
deviation and means followed by different letters (a, b, and c) are statistically different at p < 
0.05.
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Figure 2. 
MALDI-ToF mass spectrum for 3-FL (m/z 511)-spiked N-glycans released from RNase B 
using Endo BI-1.
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Figure 3. 
Relative activity of free or immobilized Endo BI-1 (on amino, epoxy, and adsorption resins) 
on the glycoprotein RNase B. Error bars represent one standard deviation. Means followed 
by different letters (a, b, and c) are statistically different at p < 0.05.
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Figure 4. 
Mean relative activity of free and immobilized enzyme at different (a) temperature and (b) 
pH values using RNase B. Error bars represent one standard deviation and means, within the 
same chart, followed by different letters (a, b, c, d, e, and f) are statistically different at p < 
0.05.
Cohen et al. Page 19
Catalysts. Author manuscript; available in PMC 2019 March 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. 
Lineweaver Burk (1/[S] (mL/mg) vs. 1/v (mL × min/mg)) (a) and Hanes–Woolf ([S] 
(mg/mL) vs. s/v (min)) (b) linearized plotting techniques for the estimation of kinetic 
parameters of free and immobilized EndoBI-1 on RNase B.
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Figure 6. 
Mean relative activity of immobilized Endo BI-1 on RNase B following several reuse cycles. 
Error bars represent one standard deviation.
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Figure 7. 
Mean relative quantities of various classes of released N-glycans from bovine colostrum 
whey proteins determined by nano-LC Chip Q-ToF MS/MS by free and immobilized Endo 
BI-1. Error bars represent one standard deviation. * Represents significant differences within 
the same class of N-glycans at p < 0.05.
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